California Public Employees Retirement System
MDGL icon

California Public Employees Retirement System’s Madrigal Pharmaceuticals MDGL Stock Holding History

California Public Employees Retirement System’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13M Buy
24,277
+1,079
+5% +$553K 0.01% 801
2026
Q1 		$12.1M Sell
23,198
-8,088
-26% -$3.86M 0.01% 809
2025
Q4 		$18.2M Buy
31,286
+7,189
+30% +$3.67M 0.01% 654
2025
Q3 		$11.1M Sell
24,097
-3,486
-13% -$1.3M 0.01% 863
2025
Q2 		$8.35M Buy
27,583
+3
+0% +$894 0.01% 931
2025
Q1 		$9.14M Buy
27,580
+6,270
+29% +$2.06M 0.01% 874
2024
Q4 		$6.58M Sell
21,310
-985
-4% -$277K ﹤0.01% 994
2024
Q3 		$4.73M Buy
22,295
+33
+0.1% +$8.44K ﹤0.01% 1097
2024
Q2 		$6.24M Buy
22,262
+2,072
+10% +$493K ﹤0.01% 1010
2024
Q1 		$5.39M Hold
20,190
– – ﹤0.01% 1071
2023
Q4 		$4.67M Sell
20,190
-4,668
-19% -$817K ﹤0.01% 1107
2023
Q3 		$3.63M Buy
24,858
+5,221
+27% +$983K ﹤0.01% 1128
2023
Q2 		$4.54M Buy
19,637
+6,699
+52% +$1.81M ﹤0.01% 1094
2023
Q1 		$3.13M Buy
+12,938
New +$3.53M ﹤0.01% 1159
2021
Q2 		– Sell
-17,900
Closed -$2.09M – 2349
2021
Q1 		$2.09M Hold
17,900
– – ﹤0.01% 1988
2020
Q4 		$1.99M Sell
17,900
-400
-2% -$48.9K ﹤0.01% 1989
2020
Q3 		$2.17M Buy
18,300
+600
+3% +$65.1K ﹤0.01% 1785
2020
Q2 		$2M Buy
17,700
+1,400
+9% +$138K ﹤0.01% 1796
2020
Q1 		$1.09M Sell
16,300
-200
-1% -$16.7K ﹤0.01% 1956
2019
Q4 		$1.5M Buy
16,500
+2,500
+18% +$242K ﹤0.01% 2176
2019
Q3 		$1.21M Buy
14,000
+7,762
+124% +$728K ﹤0.01% 2188
2019
Q2 		$654K Buy
6,238
+800
+15% +$85.7K ﹤0.01% 2405
2019
Q1 		$681K Sell
5,438
-100
-2% -$12.4K ﹤0.01% 2433
2018
Q4 		$624K Sell
5,538
-5,180
-48% -$802K ﹤0.01% 2458
2018
Q3 		$2.29M Buy
10,718
+4,810
+81% +$1.21M ﹤0.01% 1824
2018
Q2 		$1.65M Buy
5,908
+2,040
+53% +$358K ﹤0.01% 2022
2018
Q1 		$452K Buy
+3,868
New +$477K ﹤0.01% 2653
2013
Q4 		– Sell
-48
Closed -$11K – 4006
2013
Q3 		$11K Hold
48
– – ﹤0.01% 3837
2013
Q2 		$8K Buy
+48
New +$12.5K ﹤0.01% 3872

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

California Public Employees Retirement System's MDGL Position: Q2 2026 in Review

California Public Employees Retirement System increased its Madrigal Pharmaceuticals (MDGL) stake by 4.7% in Q2 2026, buying an estimated $553K and bringing the position to 24,277 shares worth $13M. The position accounts for 0.01% of the portfolio, ranked #801.

California Public Employees Retirement System first reported a position in MDGL in Q2 2013 and has held it in 29 quarters since. The position peaked at $18.2M in Q4 2025. 413 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • California Public Employees Retirement System held 24,277 shares of Madrigal Pharmaceuticals worth $13M as of Q2 2026.
  • California Public Employees Retirement System bought 1,079 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $553K.
  • Madrigal Pharmaceuticals made up 0.01% of California Public Employees Retirement System's portfolio in Q2 2026, its #801 holding.
  • California Public Employees Retirement System first reported a position in Madrigal Pharmaceuticals in Q2 2013 and has held it in 29 quarters since.
  • California Public Employees Retirement System's Madrigal Pharmaceuticals position peaked at $18.2M in Q4 2025.
  • 413 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on California Public Employees Retirement System's 13F filing for Q2 2026, filed 14 Aug 2026.